XML 28 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2013
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
In millions
Pharmacy
Services
Segment(1)
 
Retail
Pharmacy
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
March 31, 2013:
 
 
 
 
 
 
 
 
 
Net revenues
$
18,311

 
$
16,051

 
$

 
$
(3,599
)
 
$
30,763

Gross profit
768

 
4,952

 

 
(138
)
 
5,582

Operating profit (loss)
499

 
1,537

 
(199
)
 
(138
)
 
1,699

March 31, 2012:
 

 
 

 
 

 
 

 
 

Net revenues
18,300

 
16,024

 

 
(3,526
)
 
30,798

Gross profit
616

 
4,572

 

 
(75
)
 
5,113

Operating profit (loss)
349

 
1,298

 
(168
)
 
(75
)
 
1,404

Total assets:
 

 
 

 
 

 
 

 
 

March 31, 2013
35,650

 
29,552

 
1,550

 
(684
)
 
66,068

December 31, 2012
36,057

 
29,183

 
1,408

 
(736
)
 
65,912

Goodwill:
 

 
 

 
 

 
 

 
 

March 31, 2013
19,658

 
6,917

 

 

 
26,575

December 31, 2012
19,646

 
6,749

 

 

 
26,395


(1)          Net revenues of the Pharmacy Services Segment include approximately $2.2 billion and $2.3 billion of retail co-payments for the three months ended March 31, 2013 and 2012, respectively.
(2)        Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment customers, through the Company’s intersegment activities (such as the Maintenance Choice program), elect to pick-up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. The following amounts are eliminated in consolidation in connection with the item (ii) intersegment activity: net revenues of $939 million and $798 million for the three months ended March 31, 2013 and 2012, respectively, gross profit and operating profit of $138 million and $75 million for the three months ended March 31, 2013 and 2012, respectively.